These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3129444)

  • 1. Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.
    Strain GW; Zumoff B; Miller LK; Rosner W; Levit C; Kalin M; Hershcopf RJ; Rosenfeld RS
    J Clin Endocrinol Metab; 1988 May; 66(5):1019-23. PubMed ID: 3129444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
    Zumoff B; Strain GW; Miller LK; Rosner W; Levit CD; Miller EH; Rosenfeld RS
    Int J Obes; 1988; 12(6):525-31. PubMed ID: 3148562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased estrogen production in obese men.
    Schneider G; Kirschner MA; Berkowitz R; Ertel NH
    J Clin Endocrinol Metab; 1979 Apr; 48(4):633-8. PubMed ID: 429508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men.
    Croxson TS; Chapman WE; Miller LK; Levit CD; Senie R; Zumoff B
    J Clin Endocrinol Metab; 1989 Feb; 68(2):317-21. PubMed ID: 2493026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hypogonadotropic hypogonadism caused by critical illness.
    Woolf PD; Hamill RW; McDonald JV; Lee LA; Kelly M
    J Clin Endocrinol Metab; 1985 Mar; 60(3):444-50. PubMed ID: 3919042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone.
    Veldhuis JD; King JC; Urban RJ; Rogol AD; Evans WS; Kolp LA; Johnson ML
    J Clin Endocrinol Metab; 1987 Nov; 65(5):929-41. PubMed ID: 3117834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
    Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P
    Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in the effect of obesity on 24-hour mean serum gonadotropin levels.
    Strain GW; Zumoff B; Miller LK; Rosner W
    Horm Metab Res; 2003 Jun; 35(6):362-6. PubMed ID: 12920659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hypothalamic-pituitary-testicular axis in thyrotoxicosis.
    Kidd GS; Glass AR; Vigersky RA
    J Clin Endocrinol Metab; 1979 May; 48(5):798-802. PubMed ID: 372208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males.
    Abalovich M; Levalle O; Hermes R; Scaglia H; Aranda C; Zylbersztein C; Oneto A; Aquilano D; Gutierrez S
    Thyroid; 1999 Sep; 9(9):857-63. PubMed ID: 10524563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypothalamic-hypophyseal-gonadal axis in chronic alcoholic patients].
    Rallo R; Fermoso J; Ramos F; González-Calvo V; Marañón YA
    Prensa Med Mex; 1979; 44(7-8):136-44. PubMed ID: 122168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation.
    Handelsman DJ; Strasser S; McDonald JA; Conway AJ; McCaughan GW
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):331-7. PubMed ID: 7586603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.